Literature DB >> 9011307

Pharmacological characterization of desensitization in a human mGlu1 alpha-expressing non-neuronal cell line co-transfected with a glutamate transporter.

M A Desai1, J P Burnett, N G Mayne, D D Schoepp.   

Abstract

1. Stimulation of phosphoinositide hydrolysis by human mGlu1 alpha (HmGlu1 alpha) was examined in a non-neuronal cell line (AV12-664) co-expressing both HmGlu1 alpha and a rat glutamate/aspartate transporter (GLAST). 2. Desensitization of HmGlu1 alpha could be elicited by inhibition of the GLAST transporter with the glutamate uptake inhibitor, L-trans-pyrrolidine-2,4-dicarboxylic acid (trans-PDC). Maximal inhibition of HmGlu1 alpha-mediated phosphoinositide hydrolysis was induced upon 24 h pretreatment with trans-PDC. The concentration of glutamate in the extracellular medium also rose significantly in cells pretreated with trans-PDC. Glutamate levels increased upon incubation with trans-PDC in a time-dependent manner, with maximal glutamate levels attained after 24 h incubation with trans-PDC. 3. The time required for desensitization of HmGlu1 alpha by trans-PDC was compared to the time course for desensitization elicited by the direct-acting mGlu receptor agonists, 1-aminocyclopentane-1S,3R-dicarboxylic acid (1S,3R-ACPD) and (R,S)-3,5-dihydroxyphenylglycine (3,5-DHPG). Both direct-acting mGlu receptor agonists elicited desensitization of HmGlu1 alpha more rapidly than did trans-PDC, with maximal inhibition of agonist-induced phosphoinositide hydrolysis upon 12 h pretreatment. Agonist-induced desensitization could be fully reversed upon washout of agonist for 12 h. 4. Both mGlu receptor agonist- and trans-PDC-induced desensitization of HmGlu1 alpha could be blocked by inclusion of (+)-alpha-methyl-4-carboxyphenylglycine (MCPG), an mGlu receptor antagonist, in the pretreatment medium. 5. Agonist-stimulated phosphoinositide hydrolysis by HmGlu1 alpha was found to parallel closely agonist-induced desensitization of HmGlu1 alpha. Thus, the EC50 values for 1S,3R-ACPD- and 3,5-DHPG-stimulated phosphoinositide hydrolysis were similar to the EC50 values for eliciting desensitization of HmGlu1 alpha. 6. These studies demonstrate desensitization of recombinant human mGlu1 alpha receptor in a non-neuronal cell line in which the receptor can be regulated by direct activation or by manipulation of glutamate transporter activity. Desensitization of HmGlu1 alpha was found to be mediated by activation of the receptor since the mGlu receptor antagonist, MCPG, blocked both mGlu receptor agonist- and trans-PDC-induced desensitization of HmGlu1 alpha. Furthermore, agonist-induced desensitization of HmGlu1 alpha was found to parallel receptor-mediated stimulation of phosphoinositide hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9011307      PMCID: PMC1909656          DOI: 10.1111/j.1476-5381.1996.tb15574.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Rapid agonist mediated phosphorylation of the metabotropic glutamate receptor 1 alpha by protein kinase C in permanently transfected BHK cells.

Authors:  S Alaluf; E R Mulvihill; R A McIlhinney
Journal:  FEBS Lett       Date:  1995-07-03       Impact factor: 4.124

Review 4.  Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications.

Authors:  G Milligan
Journal:  Trends Pharmacol Sci       Date:  1993-11       Impact factor: 14.819

Review 5.  Desensitization of cell signalling mediated by phosphoinositidase C.

Authors:  R J Wojcikiewicz; A B Tobin; S R Nahorski
Journal:  Trends Pharmacol Sci       Date:  1993-07       Impact factor: 14.819

6.  L-glutamate uptake inhibitors may stimulate phosphoinositide hydrolysis in baby hamster kidney cells expressing mGluR1a via heteroexchange with L-glutamate without direct activation of mGluR1a.

Authors:  C Thomsen; L Hansen; P D Suzdak
Journal:  J Neurochem       Date:  1994-12       Impact factor: 5.372

7.  Chronic activation of muscarinic and metabotropic glutamate receptors down-regulates type I inositol 1,4,5-trisphosphate receptor expression in cerebellar granule cells.

Authors:  P B Simpson; R A Challiss; S R Nahorski
Journal:  J Neurochem       Date:  1994-12       Impact factor: 5.372

8.  Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporter.

Authors:  M A Desai; J P Burnett; N G Mayne; D D Schoepp
Journal:  Mol Pharmacol       Date:  1995-10       Impact factor: 4.436

9.  A pharmacological characterization of the mGluR1 alpha subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line.

Authors:  C Thomsen; E R Mulvihill; B Haldeman; D S Pickering; D R Hampson; P D Suzdak
Journal:  Brain Res       Date:  1993-08-13       Impact factor: 3.252

10.  Long-term phorbol ester treatment down-regulates protein kinase C and sensitizes the phosphoinositide signaling pathway to hormone and growth factor stimulation. Evidence for a role of protein kinase C in agonist-induced desensitization.

Authors:  J R Hepler; H S Earp; T K Harden
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

View more
  3 in total

1.  RGS4 inhibits signaling by group I metabotropic glutamate receptors.

Authors:  J A Saugstad; M J Marino; J A Folk; J R Hepler; P J Conn
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

2.  Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.

Authors:  David T Berg; Bruce Gerlitz; Jing Shang; Tommy Smith; Paula Santa; Mark A Richardson; Ken D Kurz; Brian W Grinnell; Ken Mace; Bryan E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

3.  Deficits in ventromedial prefrontal cortex group 1 metabotropic glutamate receptor function mediate resistance to extinction during protracted withdrawal from an extensive history of cocaine self-administration.

Authors:  Osnat Ben-Shahar; Arianne D Sacramento; Bailey W Miller; Sierra M Webb; Melissa G Wroten; Hannah E Silva; Amanda L Caruana; Evan J Gordon; Kyle L Ploense; Jennifer Ditzhazy; Tod E Kippin; Karen K Szumlinski
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.